Iranian dissident wounded in stabbing in the Netherlands

The man was stabbed repeatedly and suffered serious injuries, but is expected to recover. (File/AFP)
Short Url
Updated 20 June 2020

Iranian dissident wounded in stabbing in the Netherlands

  • Police in the city confirmed that a 64-year-old man was stabbed on Friday and said a 38-year-old suspect who lives in Rotterdam had been arrested at the scene
  • The man was stabbed repeatedly and suffered serious injuries, but is expected to recover

AMSTERDAM: An Iranian dissident was seriously injured in a knife attack in the northern Dutch city of Leeuwarden, a local newspaper reported on Saturday, citing the victim’s family.
The man, who was named by the Leeuwarden Courant newspaper as Sadegh Zarza, fled Iran in the 1980s and currently serves on the board of a Dutch organization that is critical of Tehran.
Police in the city confirmed that a 64-year-old man was stabbed on Friday and said a 38-year-old suspect who lives in Rotterdam had been arrested at the scene. The newspaper said the suspect was an Iranian national.
“We see that several videos of this incident are being circulated on social media,” police said in a statement. “We ask you not to re-share them.”
The man was stabbed repeatedly and suffered serious injuries, but is expected to recover.
In January 2019, the European Union ordered sanctions against Iran after France, Denmark and the Netherlands said Tehran had plotted attacks in Europe, including political killings of Iranians living in the Netherlands in 2015 and 2017.
Tehran denied any involvement in the alleged attacks.


Japan in deal to purchase AstraZeneca’s COVID-10 vaccine

Updated 4 min 46 sec ago

Japan in deal to purchase AstraZeneca’s COVID-10 vaccine

  • Japan announced a deal last week to buy 120 million doses of a COVID-19 vaccine candidate developed by Pfizer and BioNTech
TOKYO: Japan has agreed to acquire 120 million doses of AstraZeneca’s experimental COVID-19 vaccine if it is successfully developed, the health minister said on Friday.
The agreement comes after Japan announced a deal last week to buy 120 million doses of a COVID-19 vaccine candidate developed by Pfizer Inc. and BioNTech.